Supernus
SUPNNasdaq United KingdomHealth CareBiotechnology: Pharmaceutical Preparations
Market cap
$3.330 B
$28.21 +0.21%
Close of 5 Nov 2026
As of 5 Nov 2026, Supernus (SUPN) has a market capitalization of $3.33B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
$1.24B
#1393 by revenue
Earnings
$210.0M
#973 by earnings
Shares outstanding
118,035,272
Latest filing cover page
P/E ratio
15.9
Cap ÷ net income
Other share classes
Supernus lists more than one class of stock. Company figures above cover all classes combined.
Where these numbers come from
Share counts and financials for Supernus are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.